Cost-effective ways to improve the delivery and management of hepatitis B (HBV) vaccine, identified in new Burnet Institute research, have attracted interest from global policy makers including the World Health Organization ...
Jun 18, 2020
0
3
For the first time, researchers at The Westmead Institute for Medical Research (WIMR) have identified and described a new and unique subset of human cells that are involved in the immune response against hepatitis B (HBV) ...
Jun 9, 2020
0
5
University of Liverpool researchers have published new estimates of the global burden of hepatitis D, and are calling for more efforts to tackle the 'forgotten' virus.
Apr 30, 2020
0
0
(HealthDay)—The prevalence of any past or present hepatitis B virus (HBV) infection was 4.3 percent among U.S. adults during 2015 to 2018, according to a March data brief published by the U.S. Centers for Disease Control ...
Mar 25, 2020
0
0
A report in the Journal of Molecular Diagnostics describes a new and powerful laboratory tool that may improve the diagnosis and treatment of hepatitis B virus (HBV) infection. The technique can simultaneously assess several ...
Oct 10, 2019
0
23
Human apolipoprotein E (apoE) promotes hepatitis B virus (HBV) infection and production, according to a study published Aug 8 in the open-access journal PLOS Pathogens by Luhua Qiao and Guangxiang (George) Luo of the University ...
Aug 8, 2019
0
0
Princeton University researchers have developed a new, scalable cell culture system that allows for detailed investigation of how host cells respond to infection with hepatitis B (HBV) and delta virus (HDV). The paper describing ...
Jun 18, 2019
0
9
New research sheds light on how a hepatitis B viral protein stimulates the expansion of immune cells that impair antiviral responses, according to a study published April 18 in the open-access journal PLOS Pathogens by Haitao ...
Apr 18, 2019
0
62
A coalition of researchers, health organisations and patient groups on Wednesday launched an ambitious campaign to cure hepatitis B, a disease that kills twice as many people as malaria but gets far less attention.
Apr 11, 2019
0
3
Researchers from Duke-NUS Medical School, Singapore General Hospital (SGH) and Lion TCR have demonstrated that they were able to engineer HBV-specific T cells, a type of immune cells found in the body, to treat Hepatocellular ...
Mar 28, 2019
0
3
